OpenSAFELY Vaccine Coverage Report

First dose / Priority Group 1

Data from combined, up to 2021-03-07.

Vaccinated at 2021-03-07 (%) Vaccinated at 2021-03-07 (n) Population Vaccinated at 2021-02-28 (%) Vaccinated in past week (%)
Overall - 89.8% 270,081 300,916 88.4% 1.4%
Sex Female 91.9% 175,777 191,233 90.9% 1.0%
Male 86.0% 94,304 109,683 83.9% 2.0%
Ethnicity White - British 90.7% 173,271 191,044 89.3% 1.4%
White - Irish 90.8% 2,268 2,499 89.6% 1.1%
White - Any other White background 80.1% 5,026 6,272 78.8% 1.3%
Mixed - White and Black Caribbean 68.6% 413 602 66.3% 2.3%
Mixed - White and Black African 58.3% 147 252 58.3% 0.0%
Mixed - White and Asian 78.8% 182 231 72.7% 6.1%
Mixed - Any other mixed background 75.0% 357 476 70.6% 4.4%
Asian or Asian British - Indian 84.0% 1,729 2,058 82.3% 1.7%
Asian or Asian British - Pakistani 68.0% 595 875 64.8% 3.2%
Asian or Asian British - Bangladeshi 72.9% 301 413 67.8% 5.1%
Asian or Asian British - Any other Asian background 78.2% 931 1,190 75.9% 2.4%
Black or Black British - Caribbean 70.8% 1,610 2,275 68.9% 1.8%
Black or Black British - African 64.7% 910 1,407 61.7% 3.0%
Black or Black British - Any other Black background 67.0% 497 742 64.2% 2.8%
Other ethnic groups - Chinese 84.0% 294 350 80.0% 4.0%
Other ethnic groups - Any other ethnic group 74.3% 868 1,169 68.9% 5.4%
Patients with any other ethnicity code 90.4% 35,091 38,822 88.9% 1.5%
Ethnicity not stated 89.8% 2,471 2,751 89.1% 0.8%
Ethnicity not recorded 90.9% 43,029 47,362 89.9% 1.0%
Ethnicity (broad categories) White 90.4% 180,579 199,829 89.0% 1.4%
Mixed 71.2% 1,127 1,582 67.3% 4.0%
South Asian 78.4% 3,577 4,564 76.1% 2.3%
Black 68.0% 3,017 4,438 65.9% 2.1%
Other 77.0% 1,169 1,519 71.9% 5.1%
Unknown 90.6% 80,598 88,949 89.4% 1.2%
Index of Multiple Deprivation 1 (most deprived) 88.7% 94,864 107,002 87.2% 1.4%
2 88.4% 44,884 50,799 86.7% 1.6%
3 90.7% 46,354 51,121 89.3% 1.3%
4 91.2% 44,681 48,986 89.9% 1.3%
5 (least deprived) 91.8% 37,758 41,153 90.6% 1.1%
Unknown 82.4% 1,512 1,834 79.4% 3.1%
Clinical Risk Groups Patients in Any Clinical Risk Group 90.7% 235,242 259,273 89.3% 1.4%
Patients with Immunosuppression 91.5% 8,372 9,149 90.4% 1.1%
Patients with CKD 94.2% 70,448 74,823 93.5% 0.6%
Patients who have Chronic Respiratory Disease 92.3% 25,739 27,881 91.4% 0.9%
Patients with Diabetes 91.5% 51,961 56,812 90.3% 1.2%
Patients with Chronic Liver disease 86.9% 6,811 7,840 84.9% 2.0%
Patients with CNS Disease (including Stroke/TIA) 91.9% 140,028 152,292 90.7% 1.3%
Patients with Chronic heart disease 93.3% 100,940 108,185 92.5% 0.8%
Patients with Asplenia or Dysfunction of the Spleen 91.4% 2,086 2,282 90.2% 1.2%
Patients with Wider Learning Disability 84.1% 37,807 44,968 79.7% 4.4%
Patients with Severe Mental Health 82.4% 24,717 30,002 80.1% 2.3%
Other Groups Patients who are shielding (High Risk from COVID-19) 93.4% 197,666 211,554 92.7% 0.7%
Patients with Morbid Obesity 84.5% 6,888 8,148 81.4% 3.2%
Patients who are pregnant 42.1% 56 133 42.1% 0.0%